NLRP3 and type 2 diabetes mellitus: In the current study, T2DM model rats exhibited the highest AST/ALT ratio, whereas ALA treatment reduced the AST/ALT ratio, indicating that ALA may reduce the secondary signaling associated with hepatic NLRP3 inflammasome activation in the livers of T2DM model rats.